Initiation of genetic instability and tumour formation: A review and hypothesis of a nongenotoxic mechanism

Cellular and Molecular Life Sciences

Volumn 60, Issue 6, 2003, Pages 1107-1117

  Bignold, L P ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Carcinogenesis; DNA polymerase; DNA proofreading; Genetic instability; Mutation; Nongenotoxic; Stem cells; Tumour

Indexed keywords

CARCINOGEN; DNA; DNA POLYMERASE; MUTAGENIC AGENT;

CARCINOGENESIS; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMOSOME; DNA DETERMINATION; DNA METHYLATION; DNA MICROARRAY; GENE CONTROL; GENE MUTATION; GENETIC INSTABILITY; GENETIC STABILITY; GENOTOXICITY; HUMAN; MUTATION; NONHUMAN; REVIEW; STEM CELL;

EID: 0038724559     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-2314-6     Document Type: Review

References (137)

1. Rubin E. and Farber J. L. (1994) Pathology, 2nd edn, pp. 148-149, Lippincott, Philadelphia
2. Bignold L. P. (2002) The mutator phenotype/clonal selection hypothesis can provide a basis for the complex and variable morphological and behavioural features of solid tumour malignancies. Cell Mol. Life Sci. 59: 950-958
3. Bignold L. P. The mutator phenotype theory of carcinogenesis and the complex histopathology of tumours: support for the theory from the independent occurrence of nuclear abnormality, loss of specialisation and invasiveness among occasional neoplastic lesions. Cell Mol. Life Sci., in press
4. Cooper D. P., O'Connor P. J., Povey A. C. and Rafferty J. A. (1995) Cell and molecular mechansims in chemical carcinogenesis. In: Oxford Textbook of Oncology, pp. 135-147, Peckham M., Pinedo H. and Veronesi U. (eds), Oxford University Press, Oxford
5. Yuspa S. H. and Shields P. G. (1997) Etiology of cancer. Chemical factors. In: Cancer, Principles and Practice of Oncology, 5th edn, pp. 185-202, DeVita V. T. Jr, Hellman S. and Rosenberg S. A. (eds), Lippincott-Raven, Philadelphia
6. Coleman W. B. and Tsongalis G. J. (1999) The role of genomic instability in human carcinogenesis. Anticancer Res. 19: 4645-4664
7. Ried T., Heselmeyer-Haddad K., Blegen H., Schrock E. and Auer G. (1999) Genomic changes defining the genesis, progression and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195-204
8. Larson P. S., de las Morenas A., Bennett S. R., Cupples L. A. and Rosenberg C. L. (2002) Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am. J. Pathol. 161: 283-290
9. Hittelman W. N. (2001) Genetic instability in epithelial tissues at risk of cancer. Ann. N. Y. Acad. Sci. 952: 1-12
10. rd edn, Saunders, Philadelphia
11. Beattie J. M. and Dickson W. E. C. (1908) A Textbook of General Pathology, pp 239-273, Rebman, London
12. Rather L. J. (1978) The Genesis of Cancer: A Study in the History of Ideas, Johns Hopkins University Press, Baltimore
13. Inoue M. (2001) Current molecular aspects of the carcinogenesis of the uterine endometrium. Int. J. Gynecol. Cancer 11: 339-348
14. Argyris T. S. (1985) Regeneration and the mechanism of epidermal tumor promotion. Crit. Rev. Toxicol. 14: 211-258
15. Haddow A. (1972) Molecular repair, wound healing and carcinogenesis: tumor production a possible overhealing? Adv. Cancer Res. 6: 181-234
16. Apffel C. A. (1976) Nonimmunological host defenses: a review. Cancer Res. 36: 1527-1537
17. Pierce G. B. (1977) Relationship between differentiation and carcinogenesis. J Toxicol. Environ. Health 2: 1335-1342
18. Fiala S. (1968) The cancer cell as a stem cell unable to differentiate. Neoplasma 15: 607-622
19. Trosko J. E. and Chu E. H. (1975) The role of DNA repair and somatic mutation in carcinogenesis. Adv. Cancer Res. 21: 391-425
20. Braun A. C. (1981) An epigenetic model for the origin of cancer. Q. Rev. Biol. 56: 33-60
21. Muller W. A. (1999) Differentiation: a central topic in developmental and cell biology. Naturwissenschaften 86: 457-467
22. Potten C. S. (1978) Epithelial proliferative subpopulations. In: Stem Cells and Tissue Homeostasis, pp. 315-334, Cambridge University Press, Cambridge
23. Alison M. R., Poulsom R., Forbes S. and Wright N. A. (2002) An introduction to stem cells. J. Pathol. 197: 419-423.
24. th edn, pp. 235-298 and 1313-1362, Garland Science, New York
25. Nery R. (1976) Carcinogenic mechanisms: a critical review and a suggestion that oncogenesis may be adaptive ontogenesis. Chem. Biol. Interact. 12: 145-69
26. Sell S. (1993) Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ. Health Perspect. 101 Suppl. 5: 15-26
27. Ghadially F. N. (1975) Diagnostic Electron Microscopy of Tumours, Butterworths, London
28. Sachs L. (1974) Regulation of membrane changes, differentiation and malignancy in carcinogenesis. Harvey Lect. 68: 1-35
29. Jacobs I. R. (1981) Alterations in surface ultrastructure and anionic sites of rat dimethylhydrazine-induced intestinal tumors. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 37: 207-216
30. Krutovskikh V. andYamasaki H. (2000) Connexin gene mutations in human genetic diseases. Mutat. Res. 462: 197-207
31. Trosko J. E. and Chang C. C. (2001) Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat. Res. 480-481: 219-229.
32. Semenza G. L., Artemov D., Bedi A., Bhujwalla Z., Chiles K., Feldser D. et al (2001) 'The metabolism of tumours': 70 years later. Novartis Found. Symp. 240: 251-260
33. Goldberg D. M. and Diamandis E. P. (1993) Models of neoplasia and their diagnostic implications: a historical perspective. Clin. Chem. 39: 2360-2374
34. Rao K. N. (1995) The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis (review). Anticancer Res. 15: 309-314
35. Marnett L. J. (2000) Oxyradicals and DNA damage. Carcinogenesis 21: 361-370
36. Cerutti P. A. (1994) Oxy-radicals and cancer. Lancet 344: 862-863
37. Marks F., Muller-Decker K. and Furstenberger G. (2000) A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 153: 11-26
38. Lala P. K. and Chakraborty C. (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2: 149-156
39. Weinstein I. B. (1991) Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ. Health Perspect. 93: 175-179
40. Hasskarl J. and Munger K. (2002) Id proteins - tumor markers or oncogenes? Cancer Biol. Ther. 1: 91-96
41. Willis RA. (1948) Pathology of Tumours, Butterworths, London
42. Jacob F. and Monod J (1961) Genetic regulatory mechanisms in the synthesis of proteins. J Mol. Biol. 3: 318-356
43. Sherbert G. V. (1970) Epigenetic processes and their relevance to the study of neoplasia. Adv. Cancer Res. 13: 97-167
44. Foulds L. (1969) Neoplastic development, Academic Press, London
45. Rubin H. (1999) Cell damage, aging and transformation: a multilevel analysis of carcinogenesis. Anticancer Res. 19: 4877-4886
46. Mendelson J. and Lippman M. E. (1993). Principles of molecular cell biology of cancer: growth factors. In: Cancer, Principles and Practice of Oncology, 4th edn, pp. 114-133, DeVita V. T. Jr, Hellman S. and Rosenberg S. A. (eds), Lippincott-Raven, Philadelphia
47. Rozengurt E. (1995) Polypeptide and neuropeptide grqoth factos: signalling pathways and role in cancer. In: Peckham M., Pinedo H. and U Veronesi U. (eds), Oxford Textbook of Oncology, pp. 12-20, Oxford University Press, Oxford
48. Sporn M. B. and Roberts A. B. (1985) Autocrine growth factors and cancer. Nature 313: 745-747
49. Lodish H., Berk A., Zipursky S. L., Matsudaira P., Baltimore D. and Darnell J. (eds) (2000), Molecular Cell Biology, pp. 1066-1067, W. H. Freeman, New York
50. Marshall C. J. (1989) Oncogenes and cell proliferation: an overview. In: Oncogenes, pp. 1-21, D. M. Glover, and B. D. Hames (eds), IRL Press, Oxford
51. Weinberg R. A. (ed.) (1989). Oncogenes and the Molecular Origins of Cancer, Cold Spring Harbor Laboratory Press, New York
52. rd edn, p. 222, Oxford University Press, Oxford
53. Bale A. E. and Li F. P. (1997) Principles of cancer management: cancer genetics. In: Cancer: Principles and Practice of Oncology, 5th edn, pp. 285-293, DeVita, V. T., Hellman S. and Rosenberg S. A. (eds), Lippincott-Raven, Philadelphia
54. Marshall C. J. (1991) Tumor suppressor genes. Cell 64: 313-326
55. Mitchell C. D. (1991) Recessive oncogenes, antioncogenes and tumour suppression. Br. Med. Bull. 47: 136-56
56. Murphree A. L. and Benedict W. F. (1984) Retinoblastoma: clues to human oncogenesis. Science 223: 1028-1033
57. Kaelin W. G. (1999) The emerging p53 gene family. J. Natl. Cancer Inst. 91: 594-598
58. Oren M. and Rotter V. (1999) Introduction: p53 - the first twenty years. Cell Mol. Life Sci. 55: 9-11
59. Vogelstein B. and Kinzler K. W. (1993) The multistep nature of cancer. Trends Genet. 9: 138-141
60. Kinzler K. W. and Vogelstein B. (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170
61. Counts J. L. and Goodman J. I. (1994) Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol. Carcinog. 11: 185-188
62. Heard E., Clerc P. and Avner P. (1997) X-chromosome inactivation in mammals. Annu. Rev. Genet. 31: 571-610
63. Tycko B. (2000) Epigenetic gene silencing in cancer. J. Clin. Invest. 105: 401-407
64. Jones P. A. and Laird P. W. (1999) Cancer epigenetics comes of age. Nat. Genet. 21: 163-167
65. Baylin S. B. and Herman J. G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16: 168-174
66. Ehrlich M. (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-1354
67. Cox P. M. and Goding C. R. (1991) Transcription and cancer. Br. J. Cancer 63: 651-662
68. Clemens M. J. and Bommer U. A. (1999) Translational control: the cancer connection. Int. J. Biochem. Cell Biol. 31: 1-23
69. Johnson D. G. and Walker C. L. (1999) Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39: 295-312
70. Afshari C. A. and Barrett J. C. (1993) Cell cycle controls: potential targets for chemical carcinogens? Environ. Health Perspect. 101 Suppl. 5: 9-14
71. Brenton J. D., Aparicio S. A. and Caldas C. (2001) Molecular profiling of breast cancer: portraits but not physiognomy. Breast Cancer Res. 3: 77-80
72. Berenblum I. (1967) Cancer Research Today, Pergamon Press, New York
73. rd edn, pp. 622-658, Lloyd-Luke, London
74. Miller E. C. and Miller J. A. (1981) Mechanisms of chemical carcinogenesis. Cancer 47 (5 Suppl.): 1055-1064
75. Slaga T. J., O'Connell J., Rotstein J., Patskan G., Morris R., Aldaz C. M. et al. (1986) Critical genetic determinants and molecular events in multistage skin carcinogenesis. Symp. Fundam. Cancer Res. 39: 31-44.
76. Pitot H. C. (1993) The molecular biology of carcinogenesis. Cancer 72 (3 Suppl.): 962-70
77. Steen H. B. (2000) The origin of oncogenic mutations: where is the primary damage? Carcinogenesis 21: 1773-1776
78. Chu E. H., Trosko J. E. and Chang C. C. (1977) Mutational approaches to the study of carcinogenesis. J. Toxicol. Environ. Health 2: 1317-1334
79. Armitage P. (1985) Multistage models of carcinogenesis. Environ. Health Perspect. 63: 195-201
80. Day N. E. (1990) The Armitage-Doll multistage model of carcinogenesis. Stat. Med. 9: 677-679
81. Pitot H. C. (11993) Multistage carcinogenesis - genetic and epigenetic mechanisms in relation to cancer prevention. Cancer Detect. Prev. 17: 567-573
82. Trosko J. E., Chang C. C. and Madhukar B. V. (1990) Modulation of intercellular communication during radiation and chemical carcinogenesis. Radiat. Res. 123: 241-251
83. Slaga T. J., Budunova I. V., Gimenez-Conti I. B. and Aldaz C. M. (1996) The mouse skin carcinogenesis model. J. Investig. Dermatol. Symp. Proc. 1: 151-156
84. Fidler I. J. (1997). Molecular biology of cancer: invasion and metastasis. In: Cancer: Principles and Practice of Oncology, 5th edn, pp. 135-152, DeVita, V. T., Hellman S. and Rosenberg S. A. (eds), Lippincott-Raven, Philadelphia
85. Knudson A. G. (1996) Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol. 122: 135-140
86. Knudson A. G. (2000) Chasing the cancer demon. Annu. Rev. Genet. 34: 1-19
87. Knudson A. G. (2001) Two genetic hits (more or less) to cancer. Nat. Rev. Cancer. 1: 157-162
88. Suss R., Kizel V and Scriber J. D. (1973) Cancer Experiments and Concepts. Springer-Verlag, New York
89. Lawley P. D. (1994) From fluorescence spectra to mutational spectra, a historical overview and DNA-reactive compounds. IARC Scientific Publication No. 125: 3-22.
90. Skipper P. L. and Tannenbaum S. R. (1990) Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11: 507-518
91. Bartsch H. (2000) Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of inter-disciplinary research. Mutat. Res. 462: 255-279
92. Poirier M. C., Santella R. M. and Weston A. (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21: 353-359
93. Wild C. P., Law G. R. and Roman E. (2002) Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutat. Res. 499: 3-512
94. Huff J. (1993) Absence of morphologic correlation between chemical toxicity and chemical carcinogenesis. Environ. Health Perspect. 101 Suppl. 5: 45-53
95. Bartsch H. (1996) DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship. Mutat. Res. 340: 67-79
96. Garner R. C. (1998) The role of DNA adducts in chemical carcinogenesis. Mutat. Res. 402: 67-75
97. Povey A. C. (2000) DNA adducts: endogenous and induced. Toxicol. Pathol. 28: 405-414
98. Seo K. Y., Jelinsky S. A. and Loechler E. L. (2000) Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat. Res. 463: 215-246
99. Perlow RA, Broyde S. (2002) Toward understanding the mutagenicity of an environmental carcinogen: structural insights into nucleotide incorporation preferences. J. Mol. Biol. 322: 291-309
100. Perlow R. A. and Broyde S. (2001) Evading the proofreading machinery of a replicative DNA polymerase: induction of a mutation by an environmental carcinogen. J. Mol. Biol. 309: 519-536
101. Hemminki K., Koskinen M., Rajaniemi H. and Zhao C. (2000) DNA adducts, mutations, and cancer 2000. Regul. Toxicol. Pharmacol. 32: 264-275
102. Black H. S., deGruijl F. R., Forbes P. D., Cleaver J. E., Ananthaswamy H. N., deFabo E. C. et al (1997) Photocarcinogenesis: an overview. J. Photochem. Photobiol. B 40: 29-47
103. Klein C. B. and Costa M. (1997) DNA methylation, heterochromatin and epigenetic carcinogens. Mutat. Res. 386: 163-180
104. Gold L. S., Slone T. H., Stern B. R. and Bernstein L. (1993) Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals. Mutat. Res. 286: 75-100
105. Parodi S., Malacarne D. and Taningher M. (1992) Non-genotoxic factors in the carcinogenetic process: problems of detection and hazard evaluation. Toxicol. Lett. 64-65: 621-630
106. Trosko J. E. (2001) Commentary: is the concept of 'tumour promotion' a useful paradigm? Mol. Carcinog. 30: 131-137
107. Hasegawa R., Futakuchi M., Mizoguchi Y., Yamaguchi T., Shirai T., Ito N. et al (1998) Studies of initiation and promotion of carcinogenesis by N-nitroso compounds. Cancer Lett. 123: 185-191
108. Klaunig J. E., Kamendulis L. M. and Xu Y. (2000) Epigenetic mechanisms of chemical carcinogenesis. Hum. Exp. Toxicol. 19: 543-555
109. Nguyen-Ba G. and Vasseur P. (1999) Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol. Rep. 6: 925-932
110. Zeiger E. (2001) Mutagens that are not carcinogens: faulty theory or faulty tests? Mutat. Res. 492: 29-38
111. Iversen O. H. (1995) Of mice and men: a critical reappraisal of the two-stage theory of carcinogenesis. Crit. Rev. Oncog. 6: 357-405
112. Schwartz N. M. (1965) Genetic instability in Escherichia coli. J. Bacteriol. 89: 712-717.
113. Cox E. C. and Yanofsky C. (1967) Altered base ratios in the DNA of an Escherichia coli mutator strain. Proc. Natl Acad. Sci. USA 58: 1895-1902
114. Kunkel T. A. and Bebenek K. (2000) DNA replication fidelity. Ann. Rev. Biochem. 69: 497-529
115. Harfe B. D. and Jinks-Robertson S. (2000) DNA mismatch repair and genetic instability. Annu. Rev. Genet. 34: 359-399
116. Volpe J. (1990) Genetic stability and instability in turnouts. In: Molecular Biology of Cancer Genes, pp. 9-23. M. Sluyser (ed.), Ellis Horwood, New York
117. Ono S. (1971) Genetic implication of karyological instability of malignant somatic cells. Physiol. Rev. 51: 496-526.
118. Nowell P. C. (1976) The clonal evolution of tumor cell populations. Science 194: 23-28
119. Cairns J. (1975) Mutation selection and the natural history of cancer. Nature 255: 197-200
120. Cleaver J. E. (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature 218: 652-656
121. Stoler D. L., Chen N., Basik M., Kahlenberg M. S., Rodriguez-Bigas M. A., Petrelli N. J. et al. (1999) The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl Acad. Sci. USA 96: 15121-15126
122. Riley P. A. (1982) Is the establishment of a clone exhibiting defective DNA repair the initial stage of carcinogenesis? Med. Hypotheses 9: 163-168
123. Riley P. A. (1990) Is the initial event in carcinogenesis an enhancement of the mutation rate? Free Radic. Res. Commun. 11: 59-63
124. Loeb L. A. (1996) Many mutations in cancers. Cancer Surv. 28: 329-342
125. Loeb K. R. and Loeb L. A. (2000) Significance of multiple mutations in cancer. Carcinogenesis 21: 379-385
126. Loeb L. A. (2001) A mutator phenotype in cancer. Cancer Res. 61: 230-239
127. Schmutte C. and Fishel R. (1999) Genomic instability: first step to carcinogenesis. Anticancer Res. 19: 4665-4696
128. Poulsom R., Alison M. R., Forbes S. J. and Wright N. A. (2002) Adult stem cell plasticity. J. Pathol. 197: 441-456
129. MacLeod M. C. (1995) Interaction of bulky chemical carcinogens with DNA in chromatin. Carcinogenesis 16: 2009-2014
130. Bridgewater L. C., Manning F. C. and Patierno S. R. (1994) Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis 15: 2421-2427
131. Sunderman F. W. Jr (1989) Mechanisms of nickel carcinogenesis. Scand. J. Work Environ. Health 15: 1-12
132. Bal W., Kozlowski H. and Kasprzak K. S. (2000) Molecular models in nickel carcinogenesis. J. Inorg. Biochem. 79: 213-218
133. Stewart B. W. and Hristoforidis C. (1987) Persistent structural change in replicating hepatic DNA isolated from diethylnitrosamine-treated rats. Cancer Lett. 35: 263-269
134. Henderson B. E. and Feigelson H. S. (2000) Hormonal carcinogenesis. Carcinogenesis 21: 427-433
135. Ehrlichman C. and Loprinzi C. L. (1997) Hormonal therapies. In: Cancer: Principles and Practice of Oncology, 5th edn, pp. 395-405, DeVita, V. T., Hellman S. and Rosenberg S. A. (eds), Lippincott-Raven, Philadelphia
136. Nais A.H. and Fox M. (1971) Synchronization of mammalian cells with respect to the mitotic cycle. Cell Tissue Kinet. 4: 375-398
137. Tran H. T., Degtyareva N. P., Gordenin D. A. and Resnick M. A. (1999) Genetic factors affecting the impact of DNA polymerase delta proofreading activity on mutation avoidance in yeast. Genetics 152: 47-59